Elon Musk may have his eyes on Mars, but he says people should also be open to getting started and exploring psychedelics themselves.
The founder of SpaceX also predicted that as younger generations take positions of power in government, there will be greater societal embrace of its therapeutic potential. psychedelics will be.
Musk was asked about the matter at a panel event at CodeCon on Tuesday. Citing the entrepreneur's previous comments about DMT, Field Trip co-founder Ronan Levy “What role do you think psychedelics can play in addressing some of humanity's more destructive tendencies?”
"I think in general people should be open to psychedelics," Musk said. "A lot of people who make laws are from a different era, so I think as the new generation takes over political power, we'll be more receptive to the benefits of psychedelics."
While Musk encourages open-mindedness about psychedelics, he said earlier this year during an appearance on Joe Rogan's podcast that he believes that CBD of cannabis is overhyped and “does nothing”.
Elon Musk more often in the media around drugs
That exchange started with Musk and Rogan reflecting on an earlier podcast show in 2018, where the CEO of SpaceX and... Tesla puffed on a marijuana bot (which he later claimed had never actually inhaled), sparking a NASA investigation into his aerospace company's "workplace safety" and "adherence to a drug-free environment."
Musk may not be on board with CBD, but he does like to dabble in marijuana culture from time to time.
For example, when Telsa shares hit $420, Elon Musk responded on Twitter with crying, laughing emojis, saying, "Whoa... the stock is so 'high' lol."
Of course, 420 is well known among cannabis enthusiasts, as it is the unofficial cannabis holiday, 4/20, represents. And that wasn't the first time Musk starred in it either.
The billionaire tech entrepreneur ran into trouble with the Securities and Exchange Commission in 2018 after he said he was considering taking Tesla private at a $420 stock price — an announcement the SEC described as "false and misleading" and was made. without required notice to regulators.
Sources: Benzinga (EN), Marijuana Moment (EN), Psychedelic Spotlight (EN)
